Business
Announcement on Approval for Clinical Trials of the Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)
Announcement on Approval for Clinical Trials of the Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)
About this update from Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class A
Announcement on Approval for Clinical Trials of the Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells) The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment